OPKO Health, Inc. Inventory, Work in Process, Gross
OPKO Health, Inc. (OPK) had Inventory, Work in Process, Gross of $2.29 million as of 2026-06-30, per its 10-Q/A filed 2026-08-28.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2026-08-28
- 2026-06-30: Inventory, Work in Process, Gross $2.29M.
- 2026-03-31: Inventory, Work in Process, Gross $1.47M.
- 2025-12-31: Inventory, Work in Process, Gross $726.00K.
- 2025-09-30: Inventory, Work in Process, Gross $2.47M.
| Period end | Inventory, Work in Process, Gross |
|---|---|
| 2026-06-30 | $2.29M 10-Q/A · filed 2026-08-28 |
| 2026-03-31 | $1.47M 10-Q/A · filed 2026-08-28 |
| 2025-12-31 | $726.00K 10-Q/A · filed 2026-08-28 |
| 2025-09-30 | $2.47M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $2.54M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $1.59M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $2.35M 10-K · filed 2026-02-26 |
| 2024-09-30 | $2.27M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.20M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $3.29M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $1.73M 10-K · filed 2025-03-03 |
| 2023-09-30 | $2.59M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $3.67M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $2.90M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $2.45M 10-K · filed 2024-03-01 |
| 2022-09-30 | $2.58M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.89M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $2.79M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $1.61M 10-K · filed 2023-02-27 |
| 2021-09-30 | $2.77M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $3.45M 10-Q · filed 2021-07-29 |
| 2021-03-31 | $4.71M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $5.27M 10-K · filed 2022-03-01 |
| 2020-09-30 | $6.42M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $4.71M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $4.26M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $3.24M 10-K · filed 2021-02-18 |
| 2019-09-30 | $3.24M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $3.10M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $2.85M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $2.47M 10-K · filed 2020-03-02 |
| 2018-09-30 | $3.02M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $3.91M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $4.50M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $5.87M 10-K · filed 2019-03-01 |
| 2017-09-30 | $4.09M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $4.98M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $4.37M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $3.90M 8-K · filed 2019-01-29 |
| 2016-09-30 | $1.60M 10-Q · filed 2016-11-07 |
| 2016-06-30 | $1.14M 10-Q · filed 2016-08-08 |
| 2016-03-31 | $1.21M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $1.22M 10-K · filed 2017-03-01 |
| 2015-09-30 | $1.04M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $1.62M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $891.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $1.01M 10-K · filed 2016-02-29 |
| 2014-09-30 | $1.04M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $1.51M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $1.11M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $1.35M 10-K · filed 2015-02-27 |
| 2013-09-30 | $1.45M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $1.25M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $970.00K 10-Q · filed 2013-05-10 |
| 2012-12-31 | $688.00K 10-K · filed 2014-03-03 |
| 2012-09-30 | $633.00K 10-Q · filed 2012-11-09 |
| 2012-06-30 | $401.00K 10-Q · filed 2012-08-09 |
| 2011-12-31 | $277.00K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |